A form of blood cancer known as mantle cell lymphoma is critically dependent on a protein that coordinates gene expression, such that blocking its activity with an experimental drug dramatically slows the growth of this lymphoma in preclinical tests, according to a study from Weill Cornell Medicine researchers.
New York [US], June 2 (ANI): According to a preclinical study conducted by researchers at Weill Cornell Medicine, genetically engineered immune cells successfully targeted the specific cancer cells that may be responsible for relapse of acute myeloid leukaemia (AML), a type of blood cancer, and proved effective in animal models of the disease.
Washington [US], April 17 (ANI): A new study has found that cancer cells can disrupt a metabolic pathway that breaks down fats and proteins to boost the levels of a byproduct called methylmalonic acid, thereby driving metastasis.
Washington [US], April 14 (ANI): According to a new research, led by scientists at Weill Cornell Medicine, cancer cells can disrupt a metabolic pathway that breaks down fats and proteins to boost the levels of a byproduct called methylmalonic acid, thereby driving metastasis.
New York City (New York) [US], January 21 (ANI): A new study revealed that melanoma cells released small extracellular packages containing the protein nerve growth factor receptor, which primed nearby lymph nodes for tumor metastases.